Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway
Yiting Lin,
Amir Khan,
Arvin George,
Mohummad Minhaj Siddiqui
Wiley ·
2026-11-16
· DOI 10.1111/1744-1633.70074
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Yiting Lin, Amir Khan, Arvin George, Mohummad Minhaj Siddiqui. Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway. // Surgical Practice. – 2026. – DOI: 10.1111/1744-1633.70074. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1744-1633.70074?af=R
Yiting Lin, Amir Khan, Arvin George, & Mohummad Minhaj Siddiqui (2026). Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway. Surgical Practice. https://doi.org/10.1111/1744-1633.70074
Yiting Lin, et al. “Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway.” Surgical Practice, 2026. doi:10.1111/1744-1633.70074.
@article{Lin2026,
title = {Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway},
author = {Lin, Yiting and Khan, Amir and George, Arvin and Siddiqui, Mohummad Minhaj},
journal = {Surgical Practice},
year = {2026},
doi = {10.1111/1744-1633.70074},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1744-1633.70074?af=R}
}